• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本恶性胸膜间皮瘤有治愈意图手术的现状。

Japanese Current Status of Curative-Intent Surgery for Malignant Pleural Mesothelioma.

机构信息

Japanese Association for Chest Surgery, Kyoto, Japan; Department of Thoracic Surgery, Hyogo College of Medicine, Nishinomiya, Japan.

Japanese Association for Chest Surgery, Kyoto, Japan; Department of Health Policy and Management, School of Medicine, Keio University, Tokyo, Japan; Department of Healthcare Quality Assessment, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.

出版信息

Ann Thorac Surg. 2022 Apr;113(4):1348-1353. doi: 10.1016/j.athoracsur.2021.04.042. Epub 2021 Apr 27.

DOI:10.1016/j.athoracsur.2021.04.042
PMID:33930356
Abstract

BACKGROUND

Few reports about surgical outcomes in malignant pleural mesothelioma (MPM) have been based on reliable nationwide databases. Here, we analyzed the incidence, surgical outcome, and operative risk factors using Japanese nationwide database.

METHODS

Characteristics and perioperative data from 622 patients who underwent curative-intent surgery for MPM between January 2014 and December 2017 were recorded from National Clinical Database of Japan. We analyzed the incidence, surgical outcomes, and risk factors for surgical complications after 2 surgical procedures (extrapleural pneumonectomy [EPP] and pleurectomy/decortication [P/D]).

RESULTS

During 4 years, EPP was performed in 279 patients and P/D in 343. EPP was more frequently performed in institutions less experienced in MPM, while P/D was more frequently performed in institutions well experienced in MPM (P < .001), especially in high-volume centers with more than 10 cases during this period. P/D was more frequently performed, especially in high-volume centers. The morbidity rates were 45.2% in EPP and 35.9% in P/D. Heart failure and pneumonia were most frequent in EPP, while prolonged air leakage was most frequent in P/D. Thirty-day and in-hospital mortality rates were 1.1% and 3.2% (EPP) and 1.2% and 3.2% (P/D), respectively. Regression analyses revealed that higher age (>65 years) was associated with operative complications in EPP (odds ratio, 3.56 [95% confidence interval, 1.26-8.56]), whereas no risk factor was observed in P/D.

CONCLUSIONS

In Japanese nationwide annual database, P/D was more frequently performed, especially in high-volume centers. Morbidity was higher in EPP than P/D; however, the mortality rates were quite low in Japan regardless surgical procedures.

摘要

背景

很少有关于恶性胸膜间皮瘤(MPM)手术结果的报告是基于可靠的全国性数据库。在这里,我们使用日本全国性数据库分析了发病率、手术结果和手术相关危险因素。

方法

从日本全国临床数据库中记录了 2014 年 1 月至 2017 年 12 月期间 622 例接受根治性手术治疗的 MPM 患者的特征和围手术期数据。我们分析了两种手术(胸膜外全肺切除术[EPP]和胸膜切除术/剥脱术[P/D])后手术并发症的发生率、手术结果和危险因素。

结果

4 年内,279 例患者行 EPP,343 例行 P/D。EPP 在 MPM 经验较少的机构中更为常见,而 P/D 在 MPM 经验丰富的机构中更为常见(P<0.001),尤其是在该期间进行了 10 例以上手术的高容量中心。P/D 更为常见,尤其是在高容量中心。EPP 的发病率为 45.2%,P/D 为 35.9%。EPP 中最常见的是心力衰竭和肺炎,而 P/D 中最常见的是长时间漏气。EPP 的 30 天和住院死亡率分别为 1.1%和 3.2%(EPP)和 1.2%和 3.2%(P/D)。回归分析显示,EPP 中年龄较大(>65 岁)与手术并发症相关(优势比,3.56[95%置信区间,1.26-8.56]),而 P/D 中则无危险因素。

结论

在日本全国年度数据库中,P/D 更为常见,尤其是在高容量中心。EPP 的发病率高于 P/D;然而,无论手术方式如何,日本的死亡率都相当低。

相似文献

1
Japanese Current Status of Curative-Intent Surgery for Malignant Pleural Mesothelioma.日本恶性胸膜间皮瘤有治愈意图手术的现状。
Ann Thorac Surg. 2022 Apr;113(4):1348-1353. doi: 10.1016/j.athoracsur.2021.04.042. Epub 2021 Apr 27.
2
Is Pleurectomy/Decortication Superior to Extrapleural Pneumonectomy for Patients with Malignant Pleural Mesothelioma? A Single-Institutional Experience.对于恶性胸膜间皮瘤患者,胸膜切除术/纤维板剥脱术是否优于胸膜外全肺切除术?一项单机构经验。
Ann Thorac Cardiovasc Surg. 2018 Apr 20;24(2):81-88. doi: 10.5761/atcs.oa.17-00192. Epub 2018 Jan 23.
3
A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma.系统评价和荟萃分析手术治疗恶性胸膜间皮瘤。
Lung Cancer. 2014 Feb;83(2):240-5. doi: 10.1016/j.lungcan.2013.11.026. Epub 2013 Dec 6.
4
Surgical strategy for malignant pleural mesothelioma: the superiority of pleurectomy/decortication.恶性胸膜间皮瘤的外科治疗策略:胸膜切除术/剥脱术的优势。
Surg Today. 2022 Jul;52(7):1031-1038. doi: 10.1007/s00595-021-02437-9. Epub 2022 Jan 19.
5
Systematic review of quality of life following pleurectomy decortication and extrapleural pneumonectomy for malignant pleural mesothelioma.系统评价行胸膜剥脱肺切除术和胸膜外全肺切除术治疗恶性胸膜间皮瘤的生活质量。
BMC Cancer. 2018 Nov 29;18(1):1188. doi: 10.1186/s12885-018-5064-4.
6
Interim results of pleurectomy/decortication and intraoperative intrapleural hyperthermic cisplatin perfusion for patients with malignant pleural mesothelioma intolerable to extrapleural pneumonectomy.胸膜切除术/纤维板剥脱术及术中胸膜腔内顺铂热灌注治疗无法耐受胸膜外全肺切除术的恶性胸膜间皮瘤患者的中期结果
Gen Thorac Cardiovasc Surg. 2015 Jul;63(7):395-400. doi: 10.1007/s11748-015-0535-x. Epub 2015 Mar 7.
7
Combined modality treatment for malignant pleural mesothelioma: a single-centre long-term survival analysis using extrapleural pneumonectomy.恶性胸膜间皮瘤的联合治疗模式:采用胸膜外全肺切除术的单中心长期生存分析。
Eur J Cardiothorac Surg. 2019 May 1;55(5):934-941. doi: 10.1093/ejcts/ezy385.
8
Current Treatment of Mesothelioma: Extrapleural Pneumonectomy Versus Pleurectomy/Decortication.间皮瘤的当前治疗方法:胸膜外全肺切除术与胸膜剥脱术/去皮质术对比
Thorac Surg Clin. 2016 Aug;26(3):359-75. doi: 10.1016/j.thorsurg.2016.04.003.
9
Outcomes of Conversion to Extrapleural Pneumonectomy From Pleurectomy/Decortication for Malignant Pleural Mesothelioma.恶性胸膜间皮瘤行胸膜切除术/剥脱术后改行胸膜外全肺切除术的结果。
Semin Thorac Cardiovasc Surg. 2021 Autumn;33(3):873-881. doi: 10.1053/j.semtcvs.2021.02.003. Epub 2021 Feb 18.
10
Extrapleural pneumonectomy or pleurectomy/decortication for malignant pleural mesothelioma.用于恶性胸膜间皮瘤的胸膜外肺切除术或胸膜剥脱术/纤维板剥脱术
Gen Thorac Cardiovasc Surg. 2014 Sep;62(9):516-21. doi: 10.1007/s11748-014-0389-7. Epub 2014 Mar 19.

引用本文的文献

1
Pleurectomy/Decortication Versus Extrapleural Pneumonectomy in Pleural Mesothelioma: A Systematic Review and Meta-Analysis of Survival, Mortality, and Surgical Trends.胸膜间皮瘤中胸膜剥脱术/纤维板剥脱术与胸膜外全肺切除术的比较:生存、死亡率及手术趋势的系统评价和荟萃分析
J Clin Med. 2025 Aug 23;14(17):5964. doi: 10.3390/jcm14175964.
2
Pleural Mesothelioma: Pathogenesis, Diagnosis, Treatment, Prognosis, and Survival.胸膜间皮瘤:发病机制、诊断、治疗、预后及生存情况
MedComm (2020). 2025 Sep 1;6(9):e70327. doi: 10.1002/mco2.70327. eCollection 2025 Sep.
3
A bibliometric analysis of malignant pleural mesothelioma from 2010 to 2023.
2010年至2023年恶性胸膜间皮瘤的文献计量分析。
J Thorac Dis. 2025 Apr 30;17(4):2014-2027. doi: 10.21037/jtd-24-1778. Epub 2025 Apr 21.
4
Postoperative Analgesia and Length of Hospital Stay After Surgery for Malignant Pleural Mesothelioma: A Retrospective Observational Study.恶性胸膜间皮瘤手术后的术后镇痛与住院时间:一项回顾性观察研究
Anesth Pain Med. 2024 Dec 15;14(6):e150055. doi: 10.5812/aapm-150055. eCollection 2024 Dec.
5
Investigation of the appropriate viscosity of fibrinogen in repairing pleural defects using ventilation and anchoring in an ex vivo pig model.采用通气和锚固技术的体外猪模型中修复胸膜缺损时纤维蛋白原适宜黏度的研究。
J Cardiothorac Surg. 2024 Mar 21;19(1):149. doi: 10.1186/s13019-024-02643-9.
6
Nationwide prospective registry database of patients with newly diagnosed untreated pleural mesothelioma in Japan.日本新诊断未经治疗的胸膜间皮瘤患者的全国前瞻性登记数据库。
Cancer Sci. 2024 Feb;115(2):507-528. doi: 10.1111/cas.16021. Epub 2023 Dec 4.
7
Intraoperative nociception and postoperative inflammation associated with the suppression of major complications due to thoracic epidural block after pleurectomy/decortication for malignant pleural mesothelioma under general anesthesia: A retrospective observational study.全麻下单侧开胸胸膜切除/剥脱术后胸腔硬膜外阻滞对恶性胸膜间皮瘤相关主要并发症的抑制作用与术中痛觉过敏和术后炎症的关系:一项回顾性观察研究。
Medicine (Baltimore). 2023 Sep 1;102(35):e34832. doi: 10.1097/MD.0000000000034832.
8
Effects of tumor-infiltrating CD8+ T cells, PD1/PD-L1 axis, and expression patterns of HLA class I on the prognosis of patients with malignant pleural mesothelioma who underwent extra-pleural pneumonectomy.肿瘤浸润 CD8+ T 细胞、PD1/PD-L1 轴和 HLA Ⅰ类表达模式对接受胸膜外全肺切除术的恶性胸膜间皮瘤患者预后的影响。
Cancer Immunol Immunother. 2023 Apr;72(4):865-879. doi: 10.1007/s00262-022-03292-4. Epub 2022 Sep 17.
9
Clinicopathological features of male patients with breast cancer based on a nationwide registry database in Japan.日本全国注册数据库中男性乳腺癌患者的临床病理特征。
Breast Cancer. 2022 Nov;29(6):985-992. doi: 10.1007/s12282-022-01378-6. Epub 2022 Jun 22.